Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Our purpose
Reimagine medicine to improve and extend people's lives.
Our vision
Become the most valued and trusted medicines company in the world.
Our strategy
Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.
Our footprint
78k
Employees*
130
Countries**
250m+
Patients reached***
We focus on core therapeutic areas with high unmet patient needs
and technology platforms that enable cutting-edge innovative therapies
Chemistry
Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.
Biotherapeutics
Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.
xRNA
RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.
Radioligand therapy
Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.
Gene and cell therapy
Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.
In this new era, we’re ready.
Leadership
The ability to attract, grow and keep talented people is vital for us to execute our strategy and keep developing innovative products that produce better results for patients.
People and Culture
We must fundamentally reimagine the way we work and create a culture that brings out the best in our people to fulfill our purpose of reimagining medicine.
Resource Links
*Based on 2022 data except for employees which has been restated to exclude Sandoz
** Based on 2022 data, excluding Sandoz
*** Based on 2022 data, excluding Sandoz: 236 million patients reached with innovative medicines; 54 million patients reached through Novartis Global Health, which focuses on transforming health in low- and middle-income countries.